Log in
Enquire now
‌

US Patent 7601332 Vitamin receptor binding drug delivery conjugates

Patent 7601332 was granted and assigned to Endocyte on October, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Endocyte
Endocyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
76013320
Patent Inventor Names
Christopher P. Leamon0
Apparao Satyam0
Hari Krishna Santhapuram0
Iontcho R. Vlahov0
Joseph Anand Reddy0
Matthew A. Parker0
Stephen J. Howard0
Date of Patent
October 13, 2009
0
Patent Application Number
107653360
Date Filed
January 27, 2004
0
Patent Citations Received
‌
US Patent 11746123 Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
‌
US Patent 12091693 PSMA binding ligand-linker conjugates and methods for using
0
‌
US Patent 11957760 Folate receptor targeted nanoparticle drug conjugates and uses thereof
0
‌
US Patent 11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
0
‌
US Patent 11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
0
‌
US Patent 12076366 Therapeutic vitamin D conjugates
0
‌
US Patent 11744897 Folate receptor targeted nanoparticle drug conjugates and uses thereof
Patent Primary Examiner
‌
D. L. Jones
0
Patent abstract

The invention describes a vitamin receptor binding drug delivery conjugate, and preparations therefor. The drug delivery conjugate consists of a vitamin receptor binding moiety, a bivalent linker (L), and a drug. The vitamin receptor binding moiety includes vitamins, and vitamin receptor binding analogs and derivatives thereof, and the drug includes analogs and derivatives thereof. The vitamin receptor binding moiety is covalently linked to the bivalent linker, and the drug, or the analog or the derivative thereof, is covalently linked to the bivalent linker, wherein the bivalent linker (L) includes components such as spacer linkers, releasable linkers, and heteroatom linkers, and combinations thereof. Methods and pharmaceutical compositions for eliminating pathogenic cell populations using the drug delivery conjugate are also described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7601332 Vitamin receptor binding drug delivery conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.